Home / Sweden / Vicore Pharma Holding AB
Vicore Pharma Holding AB
Short position disclosed on October 26, 2026. Finansinspektionen register read on November 4, 2026.
Evolution of the disclosed total
October 1, 2024 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 1.30% | new | October 26, 2026 | |
| ActusRayPartners Limited | 0.50% | new | October 8, 2026 |
On the other side: the funds that hold Vicore Pharma Holding AB Titelia
Get the moves on Vicore Pharma Holding AB by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 26, 2026 | Citadel Advisors LLC | 1.30% | still open |
| October 23, 2026 | Citadel Advisors LLC | 1.25% | |
| October 16, 2026 | Citadel Advisors LLC | 1.10% | |
| October 12, 2026 | Citadel Advisors LLC | 1.01% | |
| October 8, 2026 | ActusRayPartners Limited | 0.50% | still open |
| October 5, 2026 | Citadel Advisors LLC | 0.90% | |
| September 29, 2026 | Citadel Advisors LLC | 0.82% | |
| September 22, 2026 | Citadel Advisors LLC | 0.71% | |
| September 15, 2026 | Citadel Advisors LLC | 0.60% | |
| September 11, 2026 | Citadel Advisors LLC | 0.54% | |
| July 31, 2026 | Qube Research & Technologies Limited | 0.70% | |
| July 10, 2026 | Qube Research & Technologies Limited | 0.61% | |
| July 9, 2026 | Qube Research & Technologies Limited | 0.59% | |
| July 8, 2026 | Qube Research & Technologies Limited | 0.60% | |
| July 7, 2026 | Qube Research & Technologies Limited | 0.59% | |
| June 11, 2026 | Qube Research & Technologies Limited | 0.70% | |
| June 4, 2026 | Qube Research & Technologies Limited | 0.61% | |
| June 1, 2026 | Qube Research & Technologies Limited | 0.50% | |
| October 1, 2024 | Jane Street Group LLC | 0.66% |
Download 19 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.36% of the capital sold short
- JM AB 7.91% of the capital sold short
- Elekta AB (publ) 7.77% of the capital sold short
- Truecaller AB 7.11% of the capital sold short
- Intrum AB 6.21% of the capital sold short
- Mips AB 5.23% of the capital sold short
- RaySearch Laboratories AB (publ) 5.15% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.15% of the capital sold short
- Cibus Real Estate AB (publ) 4.78% of the capital sold short
- Hemnet Group AB (publ) 4.67% of the capital sold short
- Aktiebolaget Electrolux 4.58% of the capital sold short
- Dynavox Group AB 4.31% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Vicore Pharma Holding AB, source Finansinspektionen, data as at October 26, 2026, https://www.quivad.com/action/vicore-pharma-holding-ab
Embed the chart
<iframe src="https://www.quivad.com/embed/action/vicore-pharma-holding-ab" width="600" height="280" title="Vicore Pharma Holding AB" loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/vicore-pharma-holding-ab"><img src="https://www.quivad.com/action/vicore-pharma-holding-ab/badge.svg" alt="QuiVad, Vicore Pharma Holding AB"></a>